Your browser doesn't support javascript.
loading
Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Maass, Alexander H; Cox, Moniek G P J.
Affiliation
  • Maass AH; Heart Center, University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, the Netherlands.
  • Cox MGPJ; Heart Center, University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, the Netherlands.
JAMA Cardiol ; 7(11): 1175, 2022 11 01.
Article in En | MEDLINE | ID: mdl-36197658
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia, Ventricular / Defibrillators, Implantable Limits: Humans Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Affiliation country: Netherlands Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia, Ventricular / Defibrillators, Implantable Limits: Humans Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Affiliation country: Netherlands Country of publication: United States